AZBio Honors Ten Arizona Legislators as Trailblazers

The 2019 AZBio Trailblazer Honorees: (Top Row Left to Right) Senator Sylvia Allen (LD6), Representative Nancy Barto, Senator Sean Bowie (LD18), Senator Kate Brophy McGee (LD28), Senator Kate Heather Carter (LD15), (LD15), (Second Row) Representative Kelli Butler (LD28), Representative Regina Cobb, DDS (LD5), Representative Jay Lawrence (LD23), Representative Amish Shah, MD (LD24), Representative Michelle Udall  (LD25)
Continue reading

Arizona Commerce Authority Announces Semifinalists in the Fall Arizona 2019 Innovation Challenge

PHOENIX, AZ (October 30, 2019) — The Arizona Commerce Authority announced today that semifinalists have been selected in the Fall 2019 Arizona Innovation Challenge (AIC). The competition is among the largest in the country and designed to advance innovation and technology commercialization opportunities in Arizona by helping early-stage ventures scale.

Continue reading

Systems Oncology Receives Investment from The Pritzker Organization

SCOTTSDALE, Ariz.–(BUSINESS WIRE)–Systems Oncology, LLC (“SO”) and The Pritzker Organization, LLC (“TPO”) announced today that Pritzker Family Business Interests advised by TPO have invested in the first closing of SO’s Series B round. The funding will be used to invest in both discovery research and pre-clinical development to evolve SO’s rapidly expanding pipeline of innovative cancer therapeutics.

Continue reading

C-Path, CDISC Develop Standard to Represent Data for Animal Rule Studies

TUCSON, Ariz. and AUSTIN, Texas, October 15, 2019 — The Critical Path Institute (C-Path) and CDISC are pleased to announce the release of a global Foundational Standard that describes how to represent data for the natural history and efficacy studies conducted in animals submitted to applications under the U.S. Food and Drug Administration (FDA) regulations commonly known as the Animal Rule. The Animal Rule provides a regulatory mechanism for the approval of drugs and licensure of biological products when human efficacy studies are not ethical or feasible.Continue reading